Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Health Focus.
Live Whole Health #281: Take a stand!
U.S. Department of Veterans Affairs
·
July 14, 2025
Ready to take a stand? Many older adults spend between 9 and 13 hours a day sitting and they struggle to add physical movement and mobility into their lives. As we age, even the day-to-day activities such as reaching for a can on a shelf, walking...
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
GlobeNewswire, Inc.
·
July 1, 2025
REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited...
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire, Inc.
·
June 23, 2025
REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered...
Aztiq sells Adalvo to EQT
GlobeNewswire, Inc.
·
July 18, 2025
Adalvo was founded in 2018 by Aztiq and is one of the leading business-to-business pharmaceutical companies in Europe EQT will support Adalvo’s next phase of growth, expanding its geographic footprint, and advancing the operational scale-up of the...
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
GlobeNewswire, Inc.
·
June 6, 2025
REYKJAVIK, Iceland, June 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
GlobeNewswire, Inc.
·
June 2, 2025
REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
GlobeNewswire, Inc.
·
May 28, 2025
Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programs The agreement includes proposed biosimilars to Ilaris® (canakinumab), Kesimpta® (ofatumumab)...
Dairy Council of California Celebrates June is Dairy Month with a Global Spotlight on Health, Culture, and Community
GlobeNewswire, Inc.
·
May 28, 2025
SACRAMENTO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Each June, the nation comes together to celebrate National Dairy Month—also known as June is Dairy Month—honoring the hard work and dedication of the dairy farm families and the dairy community...
Icelandirect Partners with Rbionutrix to Ensure Consistent Supply of High-Quality Fish Oil
EIN Presswire
·
April 9, 2025
Icelandirect partners with Rbionutrix to ensure a steady, sustainable supply of high-quality fish oil for global omega-3 customers. CLIFTON, NJ, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- Icelandirect, a leading supplier of bulk and...
Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada
GlobeNewswire, Inc.
·
May 9, 2025
REYKJAVIK, Iceland, May 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the BofA...
Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025
GlobeNewswire, Inc.
·
May 7, 2025
REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued a statement on the...
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
GlobeNewswire, Inc.
·
July 10, 2025
REYKJAVIK, Iceland, July 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda...
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
GlobeNewswire, Inc.
·
April 15, 2025
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*)...
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland
GlobeNewswire, Inc.
·
July 9, 2025
REYKJAVIK, Iceland and BURGDORF, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)
GlobeNewswire, Inc.
·
March 26, 2025
REYKJAVIK, Iceland, PISCATAWAY, N.J. and LONDON, March 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv...
Health and Wellbeing among Arctic Indigenous Peoples: Leveraging Legal Determinants of Health
The Arctic Institute
·
February 4, 2025
Back to Publications View of the U.S.-Canada fourth joint mission to map the continental shelf in the Arctic Ocean in August and September 2011. Photo: U.S Department of State The Arctic Institute Health and Wellbeing Series 2025 News Update The...
Pharmacy Management System Market Expected to Grow Consistently at 10.67% CAGR to 183.43 Billion USD
EIN Presswire
·
January 21, 2025
Pharmacy Management System Market Insights: Growing need for efficient inventory management and patient engagement drives adoption. US, NY, UNITED STATES, January 21, 2025 /EINPresswire.com/ -- Market Research Future Latest Industry Insights on...
Iceland donates an additional CHF 200,000 to WTO Fish Fund
World Trade Organization
·
January 24, 2025
Director-General Ngozi Okonjo-Iweala said: “I warmly welcome Iceland's second contribution to the WTO Fish Fund, which reflects its strong commitment to sustainable fisheries and multilateral cooperation. Building on its previous donation, this...
The International Myeloma Foundation Announces 2nd Annual Iceland Cycling Expedition, to be Held from August 27 – September 2
GlobeNewswire, Inc.
·
March 13, 2025
STUDIO CITY, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is excited to announce that the 2nd annual Iceland Cycling Expedition (ICE)—a 6-night/7-day endurance fundraiser biking expedition —will take place...
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
GlobeNewswire, Inc.
·
March 7, 2025
REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays...